U.S. Markets closed

Ligand: 4Q Earnings Snapshot

SAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Thursday reported a fourth-quarter loss of $7.4 million, after reporting a profit in the same period a year earlier.

The San Diego-based company said it had a loss of 43 cents per share. Earnings, adjusted for one-time gains and costs, were 71 cents per share.

The drugmaker posted revenue of $27 million in the period.

For the year, the company reported profit of $629.3 million, or $31.85 per share. Revenue was reported as $120.3 million.

Ligand expects full-year earnings to be $2.52 per share, with revenue expected to be $121 million.

Ligand shares have dropped 11% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $92.48, a drop of 21% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND